Table 4 Survival Analysis according to clinical stage in the SEER cohort
Clinical stage | Mean survival (months) | 95% confidence interval |
|---|---|---|
Stage IIIa | 60.259 | 59.393–61.124 |
Stage IIIb | 52.739 | 52.286–53.191 |
Stage IIIc | 41.481 | 40.584–42.378 |
T4aN2bM0 TDs (+) | 28.796 | 25.541–32.052 |
T4bN2M0 TDs (+) | 24.789 | 26.132–27.261 |
Stage IV | 29.355 | 28.616–30.094 |